Teknik Pengukuran Tingkat Keparahan Tricuspid Regurgitation (TR) Pada Pasien Dengan Pulmonary Hypertension (PH)
Article Sidebar
Main Article Content
Abstract
Background: pulmonary hypertension (PH) is a condition where there is an increase in blood pressure in the pulmonary arteries caused by a blockage of blood vessels to the lungs. Increased pulmonary pressure indicates an increase in right ventricular afterload causing further valve problems, one of which is the occurrence of a leak in the tricuspid valve or often known as Tricuspid Regurgitation (TR). The severity of TR in patients with PH can be measured using echocardiography. Method: case study. Results: an echocardiographic examination was performed on PH patients with the measurement results of the vena contracta 0.6 cm, jet area TR 61 cm. The echocardiography examination procedure uses 3 modalities M-Mode, Color doppler, and Spectrum doppler. Conclusion: the echocardiographic examination procedure in TR patients with PH using 4 measurements obtained moderate and severe results.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, illustrations, and tables.
References
Ascione G, D. F. (2020). Treatment of isolated tricuspid regurgitation in 2020. Faculty Reviews, 9.
D'Alto, M. D. (2022). Echocardiographic probability of pulmonary hypertension: a validation study. European Respiratory Journal, 60(2).
Fortmeier, V. L. (2023). Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation. Journal of the American Heart Association, 12(6).
Hahn, R. T. (2022). Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome. European Heart Journal, 23(7), 913-929.
Henning, R. J. (2022). Tricuspid valve regurgitation: Current diagnosis and treatment. American Journal of Cardiovascular Disease, 12(1).
Hoeper, M., Berger, R., Gabor, K., & Ferrari, P. (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). European Heart Journal, 43(38), 3618-3731.
Humbert, M. K. (2022). ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). European heart journal, 43(38), 3618-3731.
KEMENKES. (2022). Apa itu Ekokardiografi? Kementrian Kesehatan Direktorat Jendral Pelayanan Kesehatan.
Khan, M. S. (2023). National Estimates for the Percentage of all Readmissions With Demographic Features, Morbidity, Overall and Gender-specific Mortality of Transcutaneous vs Open Surgical Tricuspid Valve Replacement/Repair. medRxiv, 04.
Laksono, S. & Daiyansyah, S. (2022). Gambaran Ekokardiografi Jantung Bagian Kanan Pada Pasien Hipertensi Pulmonal. Human Care Journal, 7(2), 290-296.
Maron, B. A. (2021). Pulmonary arterial hypertension: diagnosis, treatment, and novel advances. American journal of respiratory and critical care medicine, 203(12), 1472-1487.
Moron, B. A. (2023). Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer. Journal of the American Heart Association, 12(8).
Perki, (2016). Pedoman Diagnosis dan Tatalaksana Hipertensi Pulmonal. Edisi Pertama, 2021
Stewart, R. H. (2022). Myocardial edema provides a link between pulmonary arterial hypertension and pericardial effusion. Circulation, 145 (11), 793-795.
Utamayasa, I. K. (2021). Clinical profile of children with rheumatic heart disease in Indonesia. Sri Lanka Journal of Child Health, 50(2), 200-202.